ICYMI - our new Series on microbiome-based therapeutics is now available

➡️ The current landscape of artificial microbiome therapeutics

➡️The use of microbiota therapeutics for inflammatory bowel disease

thelancet.com/series/Microbi…

#IBD #GITwitter #Microbiome #Microbiota

'Beginning in 2026, containers of beer, wine and liquor sold in Ireland will be required by law to bear a label in red capital letters with two warnings: “THERE IS A DIRECT LINK BETWEEN ALCOHOL AND FATAL CANCERS” & “DRINKING ALCOHOL CAUSES LIVER DISEASE.”'

#Alcohol #LiverTwitter

Global Stockpile of Cholera Vaccine Is Gone as Outbreaks Spread nytimes.com/2024/04/11/hea… via The New York Times #GITwitter #IDTwitter

'After 6 years of taking evidence, Sir Brian Langstaff’s public inquiry will finally unveil its report there on 20 May.'

theguardian.com/uk-news/2024/a…

#LiverTwitter #IDTwitter #HIV #ViralHepatitis #NoHep

A summary of what’s new in the 2024 WHO hepatitis B guidelines, from the team at World Health Organization (WHO) 👇

#WorldHepatitisSummit #NoHep #LiverTwitter

How are efforts progressing towards elimination of viral hepatitis and what needs to be done to meet 2030 targets?

Read our recent Commission update and related content ➡️ thelancet.com/commissions/vi…

#NoHep #LiverTwitter #WorldHepatitisSummit #IntegrateAccelerateEliminate

The May issue of The Lancet Gastroenterology & Hepatology is out now at thelancet.com/gastrohep!

A summary of this month's content👉linkedin.com/posts/rob-brie…

#GITwitter #LiverTwitter

Francois Renaud (World Health Organization (WHO)): Access to hepatitis medicines has yet to transition to a public health approach

#WorldHepatitisSummit #NoHep #LiverTwitter World Hepatitis Alliance

World Hepatitis Alliance World Health Organization (WHO) Low-Beer: We have a window of opportunity to have a major public health effect by 2030 — but action needs to be taken now

#WorldHepatitisReport #NoHep #HepCantWait World Health Organization (WHO) World Hepatitis Alliance #LiverTwitter

There are five key messages from the Report (below). Most notably, mortality is increasing; prevention, diagnosis, treatment coverage too low

#WorldHepatitisSummit #NoHep #LiverTwitter

Daniel Low-Beer digs into the new WHO Global Hepatitis Report…

With COVID mortality declining, viral hepatitis is likely to become the joint leading infectious cause of death globally, alongside TB

#WorldHepatitisSummit #NoHep #LiverTwitter World Health Organization (WHO)

🆕Our May issue is now live at thelancet.com/journals/langa…!

With RCTs in #Crohns , pancreatic surgery, and pancreatic cancer, a new two-part Series on #microbiome -based therapeutics, research priorities in alcohol-related liver disease, and much more! #LiverTwitter #GITwitter

Danjuma Adda opens the #WorldHepatitisSummit in Lisbon, reminding us of Martin Luther King Jr’s words, and their relevance to hepatitis elimination: “There is no deficit in human resources; the deficit is in human will.”

#NoHep #LiverTwitter World Hepatitis Alliance

Rebecca Johnson gives a powerful reminder of the importance of listening to lived experience and global indigenous peoples in efforts to eliminate viral hepatitis

#NoHep #WorldHepatitisSummit World Hepatitis Alliance

According to new WHO Global Hepatitis Report:
👉1.3 million people died from viral hepatitis in 2022—the same as tuberculosis
👉 254 million people living with hepatitis B & 50 million with hepatitis C in 2022

#NoHep #WorldHepatitisSummit #LiverTwitter World Health Organization (WHO)

Attending the #WorldHepatitisSummit ? Rob Brierley, Editor-in-Chief, invites you to reach out with enquiries.

Explore our scope, reach, impact, commitment to publishing excellence, and more: hubs.li/Q01CYmHX0

#LiverTwitter #NoHep Rob Brierley

Everyone has a fundamental right to access to quality health. Prevention, testing & treatment for #viral hepatitis should be a universal standard, not a privilege.
Ahead of #WorldHealthDay we call on all leaders to commit to the right to health by eliminating viral hepatitis.

An oncolytic virus-based immunostimulatory gene therapy + Gem/NabP, for unresectable/metastatic #PancreaticCancer : a ph 1/2 trial
👉No MTD found
👉Most common TEAE: anaemia, lymphopenia, hyperglycaemia
👉ORR 44%
👉Arm 2 underway (adding immunotherapy)

#GITwitter OncoAlert

Looking forward to #WorldHepatitisSummit next week in Lisbon; I will be co-chairing (w/ Kimberly Green, PhD, MA) an abstract session on integration & decentralisation of viral hepatitis services + leading a poster tour on April 11.

Register: lnkd.in/eNQTbGKG

#NoHep #LiverTwitter

'Australia's first unit dedicated to human challenge trials for novel vaccines and treatments has opened'

Human challenge trials crucial for development of hepatitis C vaccine -thelancet.com/journals/langa…

theguardian.com/australia-news…

#NoHep #EndHep #LiverTwitter #IDTwitter #hepC